Oppenheimer & CO Inc Pfizer Inc Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 658,388 shares of PFE stock, worth $17.6 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

658,388

Previous 604,862 8.85%

Holding current value

$17.6 Million

Previous $16.9 Million 12.58%

% of portfolio

0.3%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $1.48 Million - $1.68 Million	53,526 Added 8.85%	658,388 $19.1 Million
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $62,897 - $73,704	-2,490 Reduced 0.41%	604,862 $16.9 Million
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $2.49 Million - $2.86 Million	96,110 Added 18.8%	607,352 $16.9 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $3.61 Million - $4.69 Million	-138,238 Reduced 21.28%	511,242 $14.7 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $1.65 Million - $1.93 Million	-51,337 Reduced 7.33%	649,480 $21.5 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $606,743 - $701,988	16,798 Added 2.46%	700,817 $25.7 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $1.21 Million - $1.58 Million	30,836 Added 4.72%	684,019 $27.9 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $650,715 - $849,437	-15,586 Reduced 2.33%	653,183 $33.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.66 Million - $2.03 Million	-38,012 Reduced 5.38%	668,769 $29.3 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $1.86 Million - $2.2 Million	-39,917 Reduced 5.35%	706,781 $37.1 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $765,443 - $948,480	16,731 Added 2.29%	746,698 $38.7 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $2.17 Million - $3.22 Million	52,501 Added 7.75%	729,967 $43.1 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $103,894 - $133,461	2,647 Added 0.39%	677,466 $29.1 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $726,890 - $823,444	20,242 Added 3.09%	674,819 $26.4 Million
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $311,222 - $350,996	-9,293 Reduced 1.4%	654,577 $23.7 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $694,770 - $883,460	20,758 Added 3.23%	663,870 $24.4 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $1.36 Million - $1.59 Million	-42,762 Reduced 6.23%	643,112 $23.6 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $3.6 Million - $4.37 Million	-119,546 Reduced 14.84%	685,874 $22.4 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $950,564 - $1.36 Million	35,167 Added 4.57%	805,420 $26.3 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $489,224 - $555,206	14,861 Added 1.97%	770,253 $30.2 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $207,156 - $268,620	-6,376 Reduced 0.84%	755,392 $27.1 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $1.05 Million - $1.18 Million	-28,456 Reduced 3.6%	761,768 $33 Million
Q1 2019 Apr 24, 2019	BUY	$37.5 - $41.2 $837,562 - $920,202	22,335 Added 2.91%	790,224 $33.6 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $594,169 - $677,417	-15,445 Reduced 1.97%	767,889 $33.5 Million
Q3 2018 Oct 26, 2018	BUY	$34.47 - $41.81 $421,533 - $511,294	12,229 Added 1.59%	783,334 $34.5 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $1.62 Million - $1.73 Million	49,206 Added 6.82%	771,105 $28 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $406,278 - $471,338	12,732 Added 1.8%	721,899 $25.6 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $724,569 - $768,792	21,785 Added 3.17%	709,167 $25.7 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $21.3 Million - $23.5 Million	687,382	687,382 $24.5 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Pfizer Inc Transaction History